InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Thursday, 08/10/2017 8:56:04 AM

Thursday, August 10, 2017 8:56:04 AM

Post# of 8022
Piper Jaffray analyst Edward Tenthoff reiterated a Buy rating on Vericel Corp (NASDAQ: VCEL) yesterday and set a price target of $7. The company’s shares closed yesterday at $3.40.

Edward Tenthoff, 3 star ranked analyst.
According to TipRanks.com, Tenthoff is a 4-star analyst with an average return of 3.9% and a 43.1% success rate. Tenthoff covers the Healthcare sector, focusing on stocks such as Achillion Pharmaceuticals, Ionis Pharmaceuticals Inc, and Aevi Genomic Medicine Inc.

Currently, the analyst consensus on Vericel Corp is Moderate Buy and the average price target is $6.50, representing a 91.2% upside.

In a report released yesterday, BTIG also reiterated a Buy rating on the stock with a $6 price target.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News